Recalling firm
Wells Pharma of Houston LLC
Product type
Drug
Status
Completed
Report date
2023-12-13
Distribution
Philadelphia, Pennsylvania.
Firm state
TX
Product quantity
825 syringes
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental MonitoringReason for recall
Lack of assurance of sterility.
Product description
ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10
Code / lot info
Lot # 11092313110#01, Exp 01/12/24
Other recalls SPEQ maps to Environmental Monitoring
See all Environmental Monitoring recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.